Events

Videos

Podcasts

Articles

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


Lyudmila A. Bazhenova, MD, medical oncologist professor of medicine, University of California, San Diego, discusses the prevalence of NTRK mutations in non–small cell lung cancer.

Dr. Bazhenova on Prevalence of NTRK Mutations in NSCLC and Emerging Treatments

Several novel targeted therapies are emerging for a growing number of driver mutations in lung cancer, with multiple targeted agents now confirmed standards of care.

Targeted Therapy Options Expanding for NSCLC

Charu Aggarwal, MD, assistant professor of Medicine, University of Pennsylvania, discusses triplet therapy in EGFR-mutant lung cancer.

Dr. Aggarwal on Triplet Therapy in EGFR-Mutant Lung Cancer

Joshua Bauml, MD, assistant professor, Perelman School of Medicine, University of Pennsylvania, discusses emerging biomarkers in non–small cell lung cancer (NSCLC).

Dr. Bauml on Emerging Biomarkers in NSCLC

Rationale for Liquid Biopsies in NSCLC

Best Practices in Molecular Profiling in NSCLC

Significance of Next-Generation Sequencing in NSCLC

Treating Rare Actionable Mutations in NSCLC

Combination Therapy in BRAF-Mutant NSCLC

Treatment Considerations in ALK/ROS-1 Rearranged NSCLC

Managing Resistance to ALK Inhibitors in NSCLC

Treating ALK-Mutated NSCLC With Disease Progression

Alectinib in ALK-Mutated NSCLC

Emerging Therapies in EGFR-Positive NSCLC

EGFR TKIs as Adjuvant Therapy in NSCLC

Afatinib Therapy for Uncommon EGFR Alterations in NSCLC

Managing Resistance to EGFR TKIs in NSCLC

Resistance Mechanisms in EGFR-Positive NSCLC

Sequencing With Osimertinib in EGFR-Positive NSCLC

Osimertinib in EGFR-Positive NSCLC With Brain Metastases

The OncLive Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.

Lung Cancer

JAN-22-OSD1275 - /clinical/lung-cancer

Lung Cancer | Specialty